市場調査レポート
商品コード
1272648

遺伝子編集技術市場 - 世界および地域別分析:オファリング別、技術別、用途別、エンドユーザー別、地域別 - 分析と予測(2023年~2032年)

Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032

出版日: | 発行: BIS Research | ページ情報: 英文 240 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
遺伝子編集技術市場 - 世界および地域別分析:オファリング別、技術別、用途別、エンドユーザー別、地域別 - 分析と予測(2023年~2032年)
出版日: 2023年05月10日
発行: BIS Research
ページ情報: 英文 240 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子編集技術の市場規模は、2022年に18億1,000万米ドルとなりました。

同市場は、2023年~2032年に27.50%のCAGRで拡大し、2032年には163億7,000万米ドルに達すると予測されています。

当レポートでは、世界の遺伝子編集技術市場について調査し、市場の概要とともに、オファリング別、技術別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 製品の定義

第2章 市場の範囲

第3章 調査手法

第4章 市場概要

第5章 業界の展望

  • 規制状況
  • 製品のベンチマーク
  • 技術導入マトリックス
  • 業界の動向
  • 特許分析

第6章 世界の遺伝子編集技術市場:市場力学

  • ビジネス促進要因
  • ビジネス抑制要因
  • ビジネスの機会

第7章 世界の遺伝子編集技術市場:競合考察

  • 主な発展と戦略
  • 主要開発分析
  • 企業シェア分析

第8章 世界の遺伝子編集技術市場(オファリング別)、金額(100万米ドル)、2022年~2032年

  • 概要
  • 遺伝子編集製品
  • 遺伝子編集サービス

第9章 世界の遺伝子編集技術市場(技術別)、金額(100万米ドル)、2022年~2032年

  • 概要
  • CRISPR遺伝子編集技術
  • 非CRISPR遺伝子編集技術

第10章 世界の遺伝子編集技術市場(用途別)、金額(100万米ドル)、2022年~2032年

  • 概要
  • 農業
  • 生物医学

第11章 世界の遺伝子編集技術市場(エンドユーザー別)、金額(100万米ドル)、2022年~2032年

  • 概要
  • 学術機関および研究センター
  • ライフサイエンス企業
  • CRO/CMO

第12章 世界の遺伝子編集技術市場(地域別)、金額(100万米ドル)、2022年~2032年

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第13章 企業プロファイル

  • Addgene
  • BRAIN Biotech AG
  • Cellectis S.A.
  • Creative Biolabs
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • DNA Script
  • GeneCopoeia, Inc.
  • Magento, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • PerkinElmer Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 2: Global Gene Editing Technologies Market: Drivers, Restraints, and Opportunities
  • Figure 3: Global Gene Editing Technologies Market (by Offering), $Billion, 2022-2032
  • Figure 4: Global Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 5: Global Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 6: Global Gene Editing Technologies Market (by Region), $Billion, 2022 and 2032
  • Figure 7: Global Gene Editing Technologies Market, Share of Key Developments and Strategies (by Category), January 2018- March 2023
  • Figure 8: Global Gene Editing Technologies Market Segmentation
  • Figure 9: Global Gene Editing Technologies Market: Research Methodology
  • Figure 10: Primary Research Methodology
  • Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 12: Top-Down Approach (Segment-Wise Analysis)
  • Figure 13: Global Gene Editing Technologies Market: Market Overview
  • Figure 14: Global Gene Editing Technologies Market, Potential Forecast Scenarios, 2022-2032
  • Figure 15: Global Gene Editing Technologies Market Size and Growth Potential (Realistic Scenario), $Million, 2022-2032
  • Figure 16: Global Gene Editing Technologies Market Size and Growth Potential (Optimistic Scenario), $Million, 2022-2032
  • Figure 17: Global Gene Editing Technologies Market Size and Growth Potential (Pessimistic Scenario), $Million, 2022-2032
  • Figure 18: Evolution of Gene Editing Technologies, 1994-2020
  • Figure 19: Clinical Trial Authorization for Gene Editing
  • Figure 20: Steps for Obtaining Marketing Authorization
  • Figure 21: EMA Review Timeline
  • Figure 22: Comparison of Various Gene Editing Technologies
  • Figure 23: Global Gene Editing Technologies Market, Technology Adoption Matrix
  • Figure 24: Key Strategies Adopted by Major Players, January 2018- March 2023
  • Figure 25: Global Gene Editing Technologies Market, Patent Analysis (by Year), January 2018- December 2022
  • Figure 26: Global Gene Editing Technologies Market, Patent Analysis (by Technology), January 2018- December 2022
  • Figure 27: Global Gene Editing Technologies Market, Patent Analysis (by Region), January 2018- December 2022
  • Figure 28: Global Gene Editing Technologies Market, Patent Analysis (by Country), January 2018- December 2022
  • Figure 29: Global Gene Editing Technologies Market, Total Number of Key Developments, January 2018- March 2023
  • Figure 30: Funding Activities, January 2018- March 2023
  • Figure 31: New Offerings, January 2018- March 2023
  • Figure 32: Mergers and Acquisitions, January 2018- March 2023
  • Figure 33: Partnerships, Alliances, and Business Expansions, January 2018- March 2023
  • Figure 34: Regulatory and Legal Activities, January 2018- March 2023
  • Figure 35: Global Gene Editing Technologies Market, Company Share Analysis, % Share, 2022
  • Figure 36: Global Gene Editing Technologies Market (by Offering)
  • Figure 37: Global Gene Editing Technologies Market (Gene Editing Products), $Million, 2022-2032
  • Figure 38: Global Gene Editing Technologies Market (Kits and Enzymes), $Million, 2022-2032
  • Figure 39: Global Gene Editing Technologies Market (CRISPR), $Million, 2022-2032
  • Figure 40: Global Gene Editing Technologies Market (Vector-Based Cas9), $Million, 2022-2032
  • Figure 41: Global Gene Editing Technologies Market (DNA-Free Cas9), $Million, 2022-2032
  • Figure 42: Global Gene Editing Technologies Market (Non-CRISPR), $Million, 2022-2032
  • Figure 43: Global Gene Editing Technologies Market (Antibodies), $Million, 2022-2032
  • Figure 44: Global Gene Editing Technologies Market (Libraries), $Million, 2022-2032
  • Figure 45: Global Gene Editing Technologies Market (Accessories), $Million, 2022-2032
  • Figure 46: Global Gene Editing Technologies Market (Gene Editing Services), $Million, 2022-2032
  • Figure 47: Global Gene Editing Technologies Market (by Technology)
  • Figure 48: CRISPR Lexicon
  • Figure 49: Global Gene Editing Technologies Market (CRISPR Gene Editing Technology), $Million, 2022-2032
  • Figure 50: Global Gene Editing Technologies Market (Non-CRISPR Gene Editing Technology), $Million, 2022-2032
  • Figure 51: Global Gene Editing Technologies Market (Zinc-Finger Nucleases (ZFNs)), $Million, 2022-2032
  • Figure 52: Global Gene Editing Technologies Market (TAL Effector Nucleases (TALENs)), $Million, 2022-2032
  • Figure 53: Global Gene Editing Technologies Market (Meganucleases), $Million, 2022-2032
  • Figure 54: Global Gene Editing Technologies Market (by Application)
  • Figure 55: Advantages of Gene Editing Technologies in Agriculture
  • Figure 56: Global Gene Editing Technologies Market (Agricultural), $Million, 2022-2032
  • Figure 57: Global Gene Editing Technologies Market (Biomedical), $Million, 2022-2032
  • Figure 58: Global Gene Editing Technologies Market (Drug Discovery), $Million, 2022-2032
  • Figure 59: Gene Editing Technology Mechanism in Gene Therapy
  • Figure 60: Global Gene Editing Technologies Market (Gene Therapy), $Million, 2022-2032
  • Figure 61: Global Gene Editing Technologies Market (Diagnostics), $Million, 2022-2032
  • Figure 62: Global Gene Editing Technologies Market (by End User)
  • Figure 63: Deployment of Gene Editing Technologies
  • Figure 64: Global Gene Editing Technologies Market (Academic Institutes and Research Centers), $Million, 2022-2032
  • Figure 65: Global Gene Editing Technologies Market (Life Sciences Companies), $Million, 2022-2032
  • Figure 66: Global Gene Editing Technologies Market ((CROs)/(CMOs)) $Million, 2022-2032
  • Figure 67: Global Gene Editing Technologies Market (by Region)
  • Figure 68: North America: Market Dynamics
  • Figure 69: North America Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 70: North America Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 71: North America Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 72: U.S. Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 73: U.S. Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 74: U.S. Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 75: Canada Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 76: Canada Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 77: Canada Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 78: Europe: Market Dynamics
  • Figure 79: Europe Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 80: Europe Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 81: Europe Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 82: Germany Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 83: Germany Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 84: Germany Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 85: U.K. Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 86: U.K. Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 87: U.K. Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 88: Switzerland Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 89: Switzerland Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 90: Switzerland Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 91: France Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 92: France Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 93: France Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 94: Spain Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 95: Spain Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 96: Spain Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 97: Italy Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 98: Italy Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 99: Italy Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 100: Rest-of-Europe Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 101: Rest-of-Europe Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 102: Rest-of-Europe Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 103: Asia-Pacific: Market Dynamics
  • Figure 104: Asia-Pacific Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 105: Asia-Pacific Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 106: Asia-Pacific Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 107: China Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 108: China Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 109: China Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 110: Japan Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 111: Japan Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 112: Japan Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 113: India Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 114: India Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 115: India Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 116: Australia Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 117: Australia Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 118: Australia Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 119: Singapore Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 120: Singapore Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 121: Singapore Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 122: South Korea Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 123: South Korea Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 124: South Korea Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 125: Rest-of-Asia-Pacific Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 126: Rest-of-Asia-Pacific Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 127: Rest-of-Asia-Pacific Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 128: Latin America: Market Dynamics
  • Figure 129: Latin America Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 130: Latin America Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 131: Latin America Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 132: Brazil Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 133: Brazil Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 134: Brazil Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 135: Mexico Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 136: Mexico Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 137: Mexico Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 138: Rest-of-Latin America Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 139: Rest-of-Latin America Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 140: Rest-of-Latin America Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 141: Rest-of-the-World Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 142: Rest-of-the-World Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 143: Rest-of-the-World Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 144: Addgene: Product Portfolio
  • Figure 145: BRAIN Biotech AG: Product Portfolio
  • Figure 146: BRAIN Biotech AG: Overall Financials, $Million, 2020-2022
  • Figure 147: BRAIN Biotech AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 148: BRAIN Biotech AG: Revenue (by Region), $Million, 2020-2022
  • Figure 149: BRAIN Biotech AG: R&D Expenditure, $Million, 2020-2022
  • Figure 150: Cellectis S.A.: Product Portfolio
  • Figure 151: Cellectis S.A.: Overall Financials, $Million, 2020-2022
  • Figure 152: Cellectis S.A.: R&D Expenditure, $Million, 2020-2022
  • Figure 153: Creative Biolabs: Product Portfolio
  • Figure 154: CRISPR Therapeutics AG: Product Portfolio
  • Figure 155: CRISPR Therapeutics AG: Overall Financials, $Million, 2020-2022
  • Figure 156: CRISPR Therapeutics AG: R&D Expenditure, $Million, 2020-2022
  • Figure 157: Danaher Corporation: Product Portfolio
  • Figure 158: Danaher Corporation: Overall Financials, $Million, 2020-2022
  • Figure 159: Danaher Corporation: Revenue (by Segment), $Million, 2020-2022
  • Figure 160: Danaher Corporation: Revenue (by Region), $Million, 2020-2022
  • Figure 161: Danaher Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 162: DNA Script: Product Portfolio
  • Figure 163: GeneCopoeia, Inc.: Product Portfolio
  • Figure 164: Magento, Inc.: Product Portfolio
  • Figure 165: Merck KGaA: Product Portfolio
  • Figure 166: Merck KGaA: Overall Financials, $Million, 2020-2022
  • Figure 167: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
  • Figure 168: Merck KGaA: Revenue (by Region), $Million, 2020-2022
  • Figure 169: Merck KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 170: New England Biolabs, Inc.: Product Portfolio
  • Figure 171: PerkinElmer Inc.: Product Portfolio
  • Figure 172: PerkinElmer, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 173: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2020-2022
  • Figure 174: PerkinElmer, Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 175: PerkinElmer, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 176: Precision BioSciences, Inc.: Product Portfolio
  • Figure 177: Precision BioSciences, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 178: Precision BioSciences, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 179: Sangamo Therapeutics, Inc.: Product Portfolio
  • Figure 180: Sangamo Therapeutics, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 181: Sangamo Therapeutics, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 182: Takara Bio Inc.: Product Portfolio
  • Figure 183: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
  • Figure 184: Takara Bio Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 185: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 186: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 187: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
  • Figure 188: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
  • Figure 189: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
  • Figure 190: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Global Gene Editing Technologies Market, Impact Analysis
  • Table 2: Key Questions Answered in the Report
  • Table 3: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios
  • Table 4: Some of the Ongoing Clinical Trials Utilizing Various Gene Editing Technologies
  • Table 5: Expedited Regulatory Designations Around the World
  • Table 6: Global Gene Editing Technologies Market, Product Benchmarking (by Technology)
  • Table 7: Impact Analysis, Business Drivers
  • Table 8: Risks and Bioethical Concerns that may Arise from Utilizing CRISPR-Cas9 Technology
  • Table 9: Impact Analysis, Business Restraints
  • Table 10: Some of the Gene Editing Applications for Abiotic Stress
  • Table 11: Some of the Gene Editing Applications for Disease Resistance
  • Table 12: Global Gene Editing Technologies Market, Key Development Analysis, January 2018- March 2023
  • Table 13: The Comparison of Various Gene Editing Technologies
  • Table 14: Some of the Ongoing Clinical Trials Utilizing TALEN Gene Editing Technology
  • Table 15: Some of the Reported CRISPR-Based Diagnostics
目次
Product Code: BHL1379SA

“The global gene editing technologies market is estimated to reach $16.37 billion in 2032, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 27.50% during the forecast period 2023-2032.”

The global gene editing technologies market is strongly driven by the continuous introduction of new technologies as well as increased investments and funding from both the government and private sectors. The global gene editing technologies market has witnessed a steady growth in the number of new entrants and continuous utilization of these technologies for the development of therapies for several indications, diagnostic purposes, and drug discovery. This trend is also expected to continue over the forecast period. Therefore, the impact of the aforementioned factors is expected to drive the global gene editing technologies market in the near future.

USP of the Report

  • The major USP of the report is the inclusion of a wide range of gene editing products, including kits and enzymes, libraries, antibodies, accessories, and gene editing services that utilize CRISPR, ZFNs, TALENs, and meganucleases for various applications such as agricultural, biomedical, and others.
  • The report provides numerical projections for the application in each region and country.
  • Apart from this, the report focuses on key trends observed in the global gene editing technologies market.
  • The report also comprises key regulations, competitive landscape, key drivers and restraints, patent analysis, business model analysis, and company profiles with a detailed analysis of the strategies undertaken by the major company to strengthen its market presence.

Analyst Perspective

According to Akash Mhaskar, Principal Analyst, BIS Research, "The global gene editing technologies market is flourishing with the advent of time and the introduction of new technologies in the gene editing industry. There is constant ongoing research for the development of novel gene editing technologies. The global gene editing technologies market has witnessed a steady growth in the number of new entrants and investments in gene editing technologies, thereby driving a surge in demand for gene editing products. This trend is also expected to continue over the forecast period. Therefore, the impact of the aforementioned factors is expected to drive the global gene editing technologies market in the near future."

Key Companies Operating in The Market

Key players in the global gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

The key players profiled in the report include Addgene, BRAIN Biotech AG, Cellectis S.A., Creative Biolabs, CRISPR Therapeutics AG, Danaher Corporation, DNA Script, GeneCopoeia, Inc., Magento, Inc., Merck KGaA, New England Biolabs, Inc., PerkinElmer Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.

Key Questions Answered in the Report:

  • What are the three potential scenarios in which the global gene editing technologies market growth can unfold during 2022-2032?
  • What are the key trends influencing the global gene editing technologies market, and what is their potential for impacting the market?
  • What is the patent landscape of the global gene editing technologies market like? Which year and country witnessed the maximum patent filing between January 2018 and December 2022?
  • What are the key regulations that impact the growth of the global gene editing technologies market?
  • What are the key differences in the various genome editing technologies available in the market?
  • What are the key drivers, restraints, and opportunities for the gene editing technologies market? What will be their impact on the market in short-, mid-, and long-term duration?
  • Which offering is projected to be the fastest-growing segment during the forecast period 2023-2032?
  • Which segmentation holds the largest market share of the gene editing technologies market based on application? Which one of those segments is expected to be the fastest growing segment during the forecast period 2023-2032?
  • Who are the major end users of the gene editing technologies market? Which end user held the largest share of the market in 2022?
  • What is the competitive landscape in the global gene editing technologies market?
  • Who are the key players in the global gene editing technologies market, and what are their product offerings in the market?

Industry Overview

The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032. The growth in the global gene editing technologies market is expected to be driven by an increase in the need for personalized medicine. In addition, the introduction of new technologies fuelled the growth of gene editing technologies.

Market Lifecycle Stage

The global gene editing technologies market is in progressing phase. The creation, production, and distribution of tools and services for gene editing are under the purview of the gene editing technology market. Utilizing ways to change DNA sequences, gene editing technologies can be used to treat genetic illnesses, create disease-resistant crops, and generate study models for animals. The market for gene editing technology is made up of numerous businesses that sell CRISPR-Cas9, TALENs, and zinc finger nucleases, among other types of gene editing tools. Researchers, pharmaceutical corporations, and biotech companies employ these techniques to create novel treatments, vaccines, and diagnostic devices.

Moreover, manufacturers began to produce application-specific gene editing technologies in recent years.

Impact

Clustered regularly interspaced short palindromic repeats Cas9 (CRISPR-Cas9) and other gene editing technologies have the potential to revolutionize the healthcare sector and have a big impact on the world economy. Treatments for genetic problems and diseases such as cancer, HIV, and cystic fibrosis may become more accurate and successful because of gene editing technology. This might result in lower healthcare expenses and better patient outcomes. New intellectual property rights could be established because of the advancement of gene editing technologies, which would lead to a sharp rise in the number of patent applications.

Market Segmentation:

Segmentation 1: by Offering

  • Gene Editing Products
  • Gene Editing Services

Based on offering, the gene editing products segment in the global gene editing technologies market dominated in FY2022.

Segmentation 2: by Technology

  • CRISPR Gene Editing Technology
  • Non-CRISPR Gene Editing Technology

Based on technology, the global gene editing technologies market was dominated by the CRISPR gene editing technology segment in FY2022.

Segmentation 3: by Application

  • Agriculture
  • Biomedical

Based on application, the biomedical segment accounted for the largest share of the global gene editing technologies market in FY2022.

Segmentation 4: by End User

  • Academic Institutes and Research Centres
  • Life Sciences Companies
  • Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs)

Based on end user, the global gene editing technologies market is dominated by the life sciences companies segment in FY2022.

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

In 2022 the North America gene editing technologies market dominated the global market with a 42.85% market share, and it is expected to hold its dominance throughout the forecast period 2023-2032. However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 29.64% during the forecast period 2023-2032.

Recent Developments in the Global Gene Editing Technologies Market

  • In March 2023, Seamless Therapeutics launched with $12.5 million seed financing to advance a transformative gene editing platform based on programmable precision designer recombinases.
  • In June 2022, Precision BioSciences, Inc. entered into an exclusive worldwide in vivo gene editing research and development collaboration and license agreement with Novartis AG to develop a custom ARCUS nuclease that would be designed to insert, in vivo, a therapeutic transgene at a "safe harbor" location in the genome as a potential one-time transformative treatment option for diseases including certain hemoglobinopathies such as sickle cell disease and beta-thalassemia.
  • In November 2021, Cytovia Therapeutics, Inc. and Cellectis S.A. expanded their TALEN gene-edited iNK partnership to enable broader collaboration in China.
  • In February 2022, Integrated DNA Technologies, Inc. (IDT), a provider of global genomics solutions, introduced Alt-R HDR Donor Blocks to support researchers in advancing scientific breakthroughs in gene editing. This enhanced solution was designed to improve homology-directed repair (HDR) rates in large fragment knock-in experiments.
  • In March 2023, Intellia Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) Application for NTLA-2002. This was an in vivo investigational therapy based on CRISPR, intended for the treatment of Hereditary Angioedema (HAE).
  • In April 2022, Thermo Fisher Scientific Inc.'s latest Gibco CTS TrueCut Cas9 Protein, manufactured under Good Manufacturing Practices (GMP), facilitates genome editing for both research and manufacturing purposes, including research on CAR T-cell therapy.
  • In November 2022, Ionis Pharmaceuticals, Inc. and Metagenomi announced a collaboration that may bring together Ionis' extensive knowledge in RNA-targeted therapeutics with Metagenomi's versatile next-generation gene editing systems. The aim of this collaboration was to pursue both established and new genetic targets that may offer the potential for expanding treatment options for patients.

Demand - Drivers and Limitations

The following are the demand drivers for the global gene editing technologies market:

  • Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies
  • Increasing Investments and Funding Opportunities in Gene Editing Space
  • Increased Demand for Personalized Medicines

The market is expected to face some limitations due to the following challenges:

  • Limited Expertise and Facilities for Gene Editing Technologies
  • Ethical Considerations and Their Consequences Regarding Human Gene Editing

How can this report add value to an organization?

  • Workflow/Innovation Strategy: The gene editing technologies market (by offering) has been segmented into gene editing products and gene editing services. Moreover, the study provides the reader with a detailed understanding of the different applications of gene editing technologies in agricultural and biomedical.
  • Growth/Marketing Strategy: Gene editing technologies are being used for agricultural, biomedical, and other applications. Various companies are providing gene editing products and services, which is also the key strategy for market players to excel in the current gene editing technologies market.
  • Competitive Strategy: Key players in the global gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The success of gene editing technologies has sparked efforts to promote treatments. A stronger focus on the gene editing demand has become essential as the need to cater to the clinical and commercial production of cells, together with the growing amount of substantial clinical data resulting from these technologies, arises. The increased demand for treatments is fuelling the expansion of gene editing technology manufacturers and providing them with numerous opportunities to spread out across different regions and improve their market presence.

Key Companies Profiled:

  • Addgene
  • BRAIN Biotech AG
  • Cellectis S.A.
  • Creative Biolabs
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • DNA Script
  • GeneCopoeia, Inc.
  • Magento, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • PerkinElmer Inc.
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion Criteria

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

4 Market Overview

  • 4.1 Market Overview
  • 4.2 Market Footprint and Potential Growth Scenario
    • 4.2.1 Realistic Growth Scenario
    • 4.2.2 Optimistic Growth Scenario
    • 4.2.3 Pessimistic Growth Scenario
  • 4.3 Evolution of Gene Editing Technologies
  • 4.4 Clinical Trials

5 Industry Outlook

  • 5.1 Regulatory Landscape
    • 5.1.1 Legal Requirements and Frameworks in the U.S.
      • 5.1.1.1 Clinical Trial Authorization
      • 5.1.1.2 Marketing Authorization
      • 5.1.1.3 USFDA Guidelines for BLA Submission
      • 5.1.1.4 Post-Authorization Regulations
    • 5.1.2 Legal Requirements and Frameworks in Europe
      • 5.1.2.1 EMA Biologics License Application Process
      • 5.1.2.2 Centralized Procedure
      • 5.1.2.3 Decentralized Procedure
      • 5.1.2.4 Mutual-Recognition Procedure
      • 5.1.2.5 National Procedure
    • 5.1.3 Legal Requirements and Frameworks in Asia-Pacific
      • 5.1.3.1 Legal Requirements and Framework in Japan
    • 5.1.4 Expedited Regulatory Designations Around the World
  • 5.2 Product Benchmarking
    • 5.2.1 Product Benchmarking (by Technology)
    • 5.2.2 Comparative Analysis
  • 5.3 Technology Adoption Matrix
  • 5.4 Industry Trends
    • 5.4.1 Leveraging Collaboration as a Major Key Strategies to Create Opportunities for Gene Editing Technologies
    • 5.4.2 Growing Focus on Gene Therapies
  • 5.5 Patent Analysis
    • 5.5.1 Patent Analysis (by Year)
    • 5.5.2 Patent Analysis (by Technology)
    • 5.5.3 Patent Analysis (by Region)
    • 5.5.4 Patent Analysis (by Country)

6 Global Gene Editing Technologies Market: Market Dynamics

  • 6.1 Business Drivers
    • 6.1.1 Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies
    • 6.1.2 Increasing Investments and Funding Opportunities in Gene Editing Space
    • 6.1.3 Increased Demand for Personalized Medicines
    • 6.1.4 Impact Analysis
  • 6.2 Business Restraints
    • 6.2.1 Limited Expertise and Facilities for Gene Editing Technologies
    • 6.2.2 Ethical Considerations and Their Consequences Regarding Human Gene Editing
    • 6.2.3 Impact Analysis
  • 6.3 Business Opportunities
    • 6.3.1 Increasing Numbers of Clinical Trials Utilizing Gene Editing Technologies for the Treatment of Genetic Diseases
    • 6.3.2 Growing Applications of Gene Editing Technologies in Agri-Food Tech

7 Global Gene Editing Technologies Market: Competitive Insights

  • 7.1 Key Developments and Strategies
    • 7.1.1 Funding Activities
    • 7.1.2 New Offerings
    • 7.1.3 Mergers and Acquisitions
    • 7.1.4 Partnerships, Alliances, and Business Expansions
    • 7.1.5 Regulatory and Legal Activities
  • 7.2 Key Development Analysis
  • 7.3 Company Share Analysis

8 Global Gene Editing Technologies Market (by Offering), Value ($Million), 2022-2032

  • 8.1 Overview
  • 8.2 Gene Editing Products
    • 8.2.1 Kits and Enzymes
      • 8.2.1.1 CRISPR
        • 8.2.1.1.1 Vector-Based Cas9
        • 8.2.1.1.2 DNA-Free Cas9
      • 8.2.1.2 Non-CRISPR
    • 8.2.2 Antibodies
    • 8.2.3 Libraries
    • 8.2.4 Accessories
  • 8.3 Gene Editing Services

9 Global Gene Editing Technologies Market (by Technology), Value ($Million), 2022-2032

  • 9.1 Overview
  • 9.2 CRISPR Gene Editing Technology
  • 9.3 Non-CRISPR Gene Editing Technology
    • 9.3.1 Zinc-Finger Nucleases (ZFNs)
    • 9.3.2 TAL Effector Nucleases (TALENs)
    • 9.3.3 Meganucleases

10 Global Gene Editing Technologies Market (by Application), Value ($Million), 2022-2032

  • 10.1 Overview
  • 10.2 Agricultural
  • 10.3 Biomedical
    • 10.3.1 Drug Discovery
    • 10.3.2 Gene Therapy
    • 10.3.3 Diagnostics

11 Global Gene Editing Technologies Market (by End User), Value ($Million), 2022-2032

  • 11.1 Overview
  • 11.2 Academic Institutes and Research Centers
  • 11.3 Life Sciences Companies
  • 11.4 Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs)

12 Global Gene Editing Technologies Market (by Region), Value ($Million), 2022-2032

  • 12.1 Overview
  • 12.2 North America
    • 12.2.1 North America Gene Editing Technologies Market (by Application)
    • 12.2.2 North America Gene Editing Technologies Market (by Technology)
    • 12.2.3 North America Gene Editing Technologies Market (by Country)
      • 12.2.3.1 U.S.
        • 12.2.3.1.1 U.S. Gene Editing Technologies Market (by Application)
        • 12.2.3.1.2 U.S. Gene Editing Technologies Market (by Technology)
      • 12.2.3.2 Canada
        • 12.2.3.2.1 Canada Gene Editing Technologies Market (by Application)
        • 12.2.3.2.2 Canada Gene Editing Technologies Market (by Technology)
  • 12.3 Europe
    • 12.3.1 Europe Gene Editing Technologies Market (by Application)
    • 12.3.2 Europe Gene Editing Technologies Market (by Technology)
    • 12.3.3 Europe Gene Editing Technologies Market (by Country)
      • 12.3.3.1 Germany
        • 12.3.3.1.1 Germany Gene Editing Technologies Market (by Application)
        • 12.3.3.1.2 Germany Gene Editing Technologies Market (by Technology)
      • 12.3.3.2 U.K.
        • 12.3.3.2.1 U.K. Gene Editing Technologies Market (by Application)
        • 12.3.3.2.2 U.K. Gene Editing Technologies Market (by Technology)
      • 12.3.3.3 Switzerland
        • 12.3.3.3.1 Switzerland Gene Editing Technologies Market (by Application)
        • 12.3.3.3.2 Switzerland Gene Editing Technologies Market (by Technology)
      • 12.3.3.4 France
        • 12.3.3.4.1 France Gene Editing Technologies Market (by Application)
        • 12.3.3.4.2 France Gene Editing Technologies Market (by Technology)
      • 12.3.3.5 Spain
        • 12.3.3.5.1 Spain Gene Editing Technologies Market (by Application)
        • 12.3.3.5.2 Spain Gene Editing Technologies Market (by Technology)
      • 12.3.3.6 Italy
        • 12.3.3.6.1 Italy Gene Editing Technologies Market (by Application)
        • 12.3.3.6.2 Italy Gene Editing Technologies Market (by Technology)
      • 12.3.3.7 Rest-of-Europe
        • 12.3.3.7.1 Rest-of-Europe Gene Editing Technologies Market (by Application)
        • 12.3.3.7.2 Rest-of-Europe Gene Editing Technologies Market (by Technology)
  • 12.4 Asia-Pacific
    • 12.4.1 Asia-Pacific Gene Editing Technologies Market (by Application)
    • 12.4.2 Asia-Pacific Gene Editing Technologies Market (by Technology)
    • 12.4.3 Asia-Pacific Gene Editing Technologies Market (by Country)
      • 12.4.3.1 China
        • 12.4.3.1.1 China Gene Editing Technologies Market (by Application)
        • 12.4.3.1.2 China Gene Editing Technologies Market (by Technology)
      • 12.4.3.2 Japan
        • 12.4.3.2.1 Japan Gene Editing Technologies Market (by Application)
        • 12.4.3.2.2 Japan Gene Editing Technologies Market (by Technology)
      • 12.4.3.3 India
        • 12.4.3.3.1 India Gene Editing Technologies Market (by Application)
        • 12.4.3.3.2 India Gene Editing Technologies Market (by Technology)
      • 12.4.3.4 Australia
        • 12.4.3.4.1 Australia Gene Editing Technologies Market (by Application)
        • 12.4.3.4.2 Australia Gene Editing Technologies Market (by Technology)
      • 12.4.3.5 Singapore
        • 12.4.3.5.1 Singapore Gene Editing Technologies Market (by Application)
        • 12.4.3.5.2 Singapore Gene Editing Technologies Market (by Technology)
      • 12.4.3.6 South Korea
        • 12.4.3.6.1 South Korea Gene Editing Technologies Market (by Application)
        • 12.4.3.6.2 South Korea Gene Editing Technologies Market (by Technology)
      • 12.4.3.7 Rest-of-Asia-Pacific
        • 12.4.3.7.1 Rest-of-Asia-Pacific Gene Editing Technologies Market (by Application)
        • 12.4.3.7.2 Rest-of-Asia-Pacific Gene Editing Technologies Market (by Technology)
  • 12.5 Latin America
    • 12.5.1 Latin America Gene Editing Technologies Market (by Application)
    • 12.5.2 Latin America Gene Editing Technologies Market (by Technology)
    • 12.5.3 Latin America Gene Editing Technologies Market (by Country)
      • 12.5.3.1 Brazil
        • 12.5.3.1.1 Brazil Gene Editing Technologies Market (by Application)
        • 12.5.3.1.2 Brazil Gene Editing Technologies Market (by Technology)
      • 12.5.3.2 Mexico
        • 12.5.3.2.1 Mexico Gene Editing Technologies Market (by Application)
        • 12.5.3.2.2 Mexico Gene Editing Technologies Market (by Technology)
      • 12.5.3.3 Rest-of-Latin America
        • 12.5.3.3.1 Rest-of-Latin America Gene Editing Technologies Market (by Application)
        • 12.5.3.3.2 Rest-of-Latin America Gene Editing Technologies Market (by Technology)
  • 12.6 Rest-of-the-World
    • 12.6.1 Rest-of-the-World Gene Editing Technologies Market (by Application)
    • 12.6.2 Rest-of-the-World Gene Editing Technologies Market (by Technology)

13 Company Profiles

  • 13.1 Addgene
    • 13.1.1 Company Overview
    • 13.1.2 Role of Addgene in the Global Gene Editing Technologies Market
    • 13.1.3 Major Products: Key Specifications
    • 13.1.4 Key Competitors
    • 13.1.5 Analyst Perspective
  • 13.2 BRAIN Biotech AG
    • 13.2.1 Company Overview
    • 13.2.2 Role of BRAIN Biotech AG in the Global Gene Editing Technologies Market
    • 13.2.3 Major Product: Key Specifications
    • 13.2.4 Key Competitors
    • 13.2.5 Financials
    • 13.2.6 Key Insights about the Financial Health of the Company
    • 13.2.7 Analyst Perspective
  • 13.3 Cellectis S.A.
    • 13.3.1 Company Overview
    • 13.3.2 Role of Cellectis S.A. in the Global Gene Editing Technologies Market
    • 13.3.3 Major Product: Key Specifications
    • 13.3.4 Key Competitors
    • 13.3.5 Financials
    • 13.3.6 Key Insights about the Financial Health of the Company
    • 13.3.7 Analyst Perspective
  • 13.4 Creative Biolabs
    • 13.4.1 Company Overview
    • 13.4.2 Role of Creative Biolabs in the Global Gene Editing Technologies Market
    • 13.4.3 Major Products: Key Specifications
    • 13.4.4 Key Competitors
    • 13.4.5 Analyst Perspective
  • 13.5 CRISPR Therapeutics AG
    • 13.5.1 Company Overview
    • 13.5.2 Role of CRISPR Therapeutics AG in the Global Gene Editing Technologies Market
    • 13.5.3 Major Product: Key Specifications
    • 13.5.4 Key Competitors
    • 13.5.5 Financials
    • 13.5.6 Key Insights about the Financial Health of the Company
    • 13.5.7 Analyst Perspective
  • 13.6 Danaher Corporation
    • 13.6.1 Company Overview
    • 13.6.2 Role of Danaher Corporation in the Global Gene Editing Technologies Market
    • 13.6.3 Major Products: Key Specifications
    • 13.6.4 Key Competitors
    • 13.6.5 Financials
    • 13.6.6 Key Insights about the Financial Health of the Company
    • 13.6.7 Analyst Perspective
  • 13.7 DNA Script
    • 13.7.1 Company Overview
    • 13.7.2 Role of DNA Script in the Global Gene Editing Technologies Market
    • 13.7.3 Major Products: Key Specifications
    • 13.7.4 Key Competitors
    • 13.7.5 Analyst Perspective
  • 13.8 GeneCopoeia, Inc.
    • 13.8.1 Company Overview
    • 13.8.2 Role of GeneCopoeia, Inc. in the Global Gene Editing Technologies Market
    • 13.8.3 Major Product: Key Specifications
    • 13.8.4 Key Competitors
    • 13.8.5 Analyst Perspective
  • 13.9 Magento, Inc.
    • 13.9.1 Company Overview
    • 13.9.2 Role of Magento, Inc. in the Global Gene Editing Technologies Market
    • 13.9.3 Major Products: Key Specifications
    • 13.9.4 Key Competitors
    • 13.9.5 Analyst Perspective
  • 13.1 Merck KGaA
    • 13.10.1 Company Overview
    • 13.10.2 Role of Merck KGaA in the Global Gene Editing Technologies Market
    • 13.10.3 Major Products: Key Specifications
    • 13.10.4 Key Competitors
    • 13.10.5 Financials
    • 13.10.6 Key Insights about the Financial Health of the Company
    • 13.10.7 Analyst Perspective
  • 13.11 New England Biolabs, Inc.
    • 13.11.1 Company Overview
    • 13.11.2 Role of New England Biolabs, Inc. in the Global Gene Editing Technologies Market
    • 13.11.3 Major Products: Key Specifications
    • 13.11.4 Key Competitors
    • 13.11.5 Analyst Perspective
  • 13.12 PerkinElmer Inc.
    • 13.12.1 Company Overview
    • 13.12.2 Role of PerkinElmer Inc. in the Global Gene Editing Technologies Market
    • 13.12.3 Major Product: Key Specifications
    • 13.12.4 Key Competitors
    • 13.12.5 Financials
    • 13.12.6 Key Insights about the Financial Health of the Company
    • 13.12.7 Analyst Perspective
  • 13.13 Precision BioSciences, Inc.
    • 13.13.1 Company Overview
    • 13.13.2 Role of Precision BioSciences, Inc. in the Global Gene Editing Technologies Market
    • 13.13.3 Major Product: Key Specifications
    • 13.13.4 Key Competitors
    • 13.13.5 Financials
    • 13.13.6 Key Insights about the Financial Health of the Company
    • 13.13.7 Analyst Perspective
  • 13.14 Sangamo Therapeutics, Inc.
    • 13.14.1 Company Overview
    • 13.14.2 Role of Sangamo Therapeutics, Inc. in the Global Gene Editing Technologies Market
    • 13.14.3 Major Product: Key Specifications
    • 13.14.4 Key Competitors
    • 13.14.5 Financials
    • 13.14.6 Key Insights about the Financial Health of the Company
    • 13.14.7 Analyst Perspective
  • 13.15 Takara Bio Inc.
    • 13.15.1 Company Overview
    • 13.15.2 Role of Takara Bio Inc. in the Global Gene Editing Technologies Market
    • 13.15.3 Major Products: Key Specifications
    • 13.15.4 Key Competitors
    • 13.15.5 Financials
    • 13.15.6 Key Insights about the Financial Health of the Company
    • 13.15.7 Analyst Perspective
  • 13.16 Thermo Fisher Scientific Inc.
    • 13.16.1 Company Overview
    • 13.16.2 Role of Thermo Fisher Scientific Inc. in the Global Gene Editing Technologies Market
    • 13.16.3 Major Products: Key Specifications
    • 13.16.4 Key Competitors
    • 13.16.5 Financials
    • 13.16.6 Key Insights about the Financial Health of the Company
    • 13.16.7 Analyst Perspective